Altium Capital Management »

Harbor Custom Development In shares owned by Altium Capital Management

Quarter-by-quarter ownership of Harbor Custom Development In (HCDWQ) shares owned by Altium Capital Management from 13F filings

Historical chart of Altium Capital Management investment in Harbor Custom Development In

Tip: Access up to 7 years of quarterly data

All positions including Harbor Custom Development In held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Harbor Custom Development In by Altium Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $4.5k 600k 0.01
2023-06-30 $4.2k 600k 0.01
2023-03-31 $15k 600k 0.02
2022-12-31 $17k 600k 0.03
2022-09-30 $91k 600k 0.15
2022-06-30 $116k 600k 0.19
2022-03-31 $171k 600k 0.29
2021-12-31 $234k 600k 0.39
2021-09-30 $204k 600k 0.34
2021-06-30 $378k 600k 0.63

More positions owned by Altium Capital Management

Cymabay Therapeutics
Immunovant Put Put Option
ImmunoGen
Astria Therapeutics (ATXS)
Xtant Med Hldgs Com New (XTNT)
Amylyx Pharmaceuticals (AMLX)
Adma Biologics (ADMA)
Alimera Sciences Com New (ALIM)
Structure Therapeutics Sponsored Ads (GPCR)
Crinetics Pharmaceuticals In (CRNX)
Xenon Pharmaceuticals (XENE)
Biohaven (BHVN)
Axsome Therapeutics (AXSM)
Karuna Therapeutics Ord
Moonlake Immunotherapeutics Class A Ord (MLTX)

View all positions for Altium Capital Management

Top funds holding Harbor Custom Development In

Mercer Global Advisors

View all funds holding Harbor Custom Development In